AFYREN announces its 2022 annual financial results
A successful 2022 in commercial, industrial, and extra-financial terms:
- Inauguration of the group’s first factory, AFYREN NEOXY
- Commercial success: 75% of annual acid volume and 100% of fertilizer already pre-sold
- Futher improved extr-financial rating (78/100 vs. 66 published and 72 adjusted)
Teams fully mobilized at the start of 2023:
- Reliability testing and tuning is in progress at AFYREN NEOXY plant, and clients have confirmed commitments for orders totaling €165 million in revenue
- International expansion is confirmed, with the project for a second factory in Thailand
A solid financial situation at the end of 2022:
- Net loss in line with expectations: delivery and start-up of the AFYREN NEOXY plant, as well as development costs of next plants and innovation projects
- Limited cash consumption: €62.3 million of cash available as of December 31, 2022, to continue executing the medium-term strategy presented at the IPO
To find out more, download our press release.
Last news
AFYREN raises €7 million through share capital increase to support its industrial deployment
Press release
AFYREN obtains FSSC22000 certification for its AFYREN NEOXY plant, recognizing excellence in food safety quality
News post Press release
AFYREN NEOXY: first significant revenue and growing production in 2025
News post Press release AFYREN confirms drawdown of €7 million in previously secured financing for its subsidiary AFYREN NEOXY
News post Press release
AFYREN awarded Silver Medal by EcoVadis for CSR performance, ranking in the top 8% worldwide
Press release
AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance.
Press release AFYREN raises €23 million through share capital increase to finance optimization and expansion of unique biorefinery AFYREN NEOXY
Press release
